155 related articles for article (PubMed ID: 8188532)
21. Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas.
van Laarhoven HW; Gambarota G; Heerschap A; Lok J; Verhagen I; Corti A; Toma S; Gallo Stampino C; van der Kogel A; Punt CJ
Invest New Drugs; 2006 Jan; 24(1):27-36. PubMed ID: 16379040
[TBL] [Abstract][Full Text] [Related]
22. Antitumour effects of tumour necrosis factor: cytotoxic or necrotizing activity and its mechanism.
Haranaka K; Satomi N; Sakurai A; Haranaka R
Ciba Found Symp; 1987; 131():140-53. PubMed ID: 3450479
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of recombinant human tumor necrosis factor by scheduled intratumoral administration in mice bearing transplantable tumors.
Tamura K; Aso H; Nakamura T; Hemmi H; Ishida N
Tohoku J Exp Med; 1989 Feb; 157(2):107-18. PubMed ID: 2711380
[TBL] [Abstract][Full Text] [Related]
24. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
25. Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
Fujimoto S; Kobayashi K; Takahashi M; Konno C; Kokubun M; Ohta M; Shrestha RD; Kiuchi S
Br J Cancer; 1992 Jan; 65(1):33-6. PubMed ID: 1733439
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature.
Stoelcker B; Ruhland B; Hehlgans T; Bluethmann H; Luther T; Männel DN
Am J Pathol; 2000 Apr; 156(4):1171-6. PubMed ID: 10751341
[TBL] [Abstract][Full Text] [Related]
27. Negative regulatory role of PI3-kinase in TNF-induced tumor necrosis.
Matschurat S; Blum S; Mitnacht-Kraus R; Dijkman HB; Kanal L; De Waal RM; Clauss M
Int J Cancer; 2003 Oct; 107(1):30-7. PubMed ID: 12925953
[TBL] [Abstract][Full Text] [Related]
28. Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells.
Fujii S; Liu Y; Neda H; Itoh Y; Koshita Y; Takahashi M; Watanabe N; Kohgo Y; Niitsu Y
Jpn J Cancer Res; 1994 Mar; 85(3):315-24. PubMed ID: 8188531
[TBL] [Abstract][Full Text] [Related]
29. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma.
Zhang Y; Deng Y; Wendt T; Liliensiek B; Bierhaus A; Greten J; He W; Chen B; Hach-Wunderle V; Waldherr R; Ziegler R; Männel D; Stern DM; Nawroth PP
J Clin Invest; 1996 May; 97(10):2213-24. PubMed ID: 8636400
[TBL] [Abstract][Full Text] [Related]
30. Docetaxel and hyperthermia: factors that modify thermal enhancement.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
J Surg Oncol; 2004 Oct; 88(1):14-20. PubMed ID: 15384091
[TBL] [Abstract][Full Text] [Related]
31. Toxic effect of tumor necrosis factor on tumor vasculature in mice.
Watanabe N; Niitsu Y; Umeno H; Kuriyama H; Neda H; Yamauchi N; Maeda M; Urushizaki I
Cancer Res; 1988 Apr; 48(8):2179-83. PubMed ID: 3349488
[TBL] [Abstract][Full Text] [Related]
32. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
[TBL] [Abstract][Full Text] [Related]
33. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
[TBL] [Abstract][Full Text] [Related]
34. Febrile and acute hyperthermia enhance TNF-induced necrosis of murine L929 fibrosarcoma cells via caspase-regulated production of reactive oxygen intermediates.
Leroux E; Auzenne E; Weidner D; Wu ZY; Donato NJ; Klostergaard J
J Cell Physiol; 2001 May; 187(2):256-63. PubMed ID: 11268005
[TBL] [Abstract][Full Text] [Related]
35. [The mechanism of action of tumor necrosis factor (TNF) on tumor vascularity--study using a transparent chamber].
Watanabe N; Niitsu Y; Umeno H; Kuriyama H; Neda H; Yamauchi N; Maeda M; Urushizaki I
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3337-43. PubMed ID: 3318706
[TBL] [Abstract][Full Text] [Related]
36. Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity.
Kianmanesh A; Hackett NR; Lee JM; Kikuchi T; Korst RJ; Crystal RG
Hum Gene Ther; 2001 Nov; 12(17):2035-49. PubMed ID: 11747595
[TBL] [Abstract][Full Text] [Related]
37. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms.
Worrall NK; Chang K; LeJeune WS; Misko TP; Sullivan PM; Ferguson TB; Williamson JR
Am J Physiol; 1997 Dec; 273(6):H2565-74. PubMed ID: 9435588
[TBL] [Abstract][Full Text] [Related]
38. Enhanced cytotoxicity and suppression of glucose transport rate by combined treatment of recombinant human tumour necrosis factor-alpha and hyperthermia on L929 cells.
Liong E; Kong SK; Au KK; Li JY; Xu GY; Lee YL; Kwok TT; Choy YM; Lee CY; Fung KP
Life Sci; 1999; 65(8):PL81-6. PubMed ID: 10466752
[TBL] [Abstract][Full Text] [Related]
39. TNF receptor number-dependent cytotoxicity to TNF-resistant human esophageal cancer cell lines by combination with recombinant human necrosis factor and hyperthermia.
Saito T; Kato H; Saito M; Karaki Y; Tazawa K; Fujimaki M
Hum Cell; 1994 Mar; 7(1):55-61. PubMed ID: 8025021
[TBL] [Abstract][Full Text] [Related]
40. Effects of tumor necrosis factor-alpha on tumor blood flow and hyperthermic treatment.
Kallinowski F; Moehle R; Schaefer C; Vaupel P
Onkologie; 1989 Jun; 12(3):131-5. PubMed ID: 2668835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
